Amid the debate over menopausal hormone therapy and cancer risk, researchers at SABCS provided some clarity for women with...
Dr. Alan D’Andrea spoke about a new grant looking for fresh perspectives in Fanconi anemia-related cancer research.
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
Researchers at the AACR Annual Meeting 2024 examined new treatment options for brain tumors.
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.
Insights from the AACR Cancer Disparities Progress Report 2024.
Experience the annual undergraduate poster competition at the AACR Annual Meeting through photos.
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.